— Know what they know.
Not Investment Advice

NXEN OTC

Nexien BioPharma, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -99.2% 3Y: -99.8% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $7077 mcap · 31M float · 0.0011% daily turnover · Short 64% of daily vol

Balance Sheet Trends

Total Assets
$4K -90.3% ▼
5Y CAGR: -57.7%
Total Liabilities
$365K +23.8% ▲
5Y CAGR: +52.2%
Shareholders Equity
-$361K -43.3% ▼
Cash & Investments
$4K -88.1% ▼
5Y CAGR: -50.9%
Total Debt
$312K +15.0% ▲
Net Debt
$308K +30.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$11K$18K$117K$35K$4K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$11K$18K$117K$35K$4K
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$23K$26K$125K$43K$4K
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$0$0$0
Total Assets$23K$26K$125K$43K$4K
— Liabilities —
Accounts Payable$17K$6K$20K$24K$53K
Short-Term Debt$12K$13K$222K$271K$312K
Deferred Revenue-$17K$0$0$0$0
Other Current Liabilities$17K$20K$0$0$0
Total Current Liabilities$29K$39K$242K$295K$365K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$29K$39K$242K$295K$365K
— Equity —
Common Stock$5K$6K$6K$6K$7K
Retained Earnings-$8M-$10M-$11M-$11M-$12M
Accumulated OCI-$3K-$188K$51K$51K$0
Total Stockholders Equity-$6K-$14K-$118K-$252K-$361K
Total Liabilities & Equity$23K$26K$125K$43K$4K
— Key Metrics —
Total Debt$12K$13K$222K$271K$312K
Net Debt$1K-$5K$60K$236K$308K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms